Literature DB >> 24267682

Sarcoids.

Kerstin E Bergvall1.   

Abstract

Sarcoids are the most common skin tumors seen in horses worldwide. The pathogenesis of sarcoids is multifactorial, including an association with bovine papillomavirus types 1 and 2 and a genetic susceptibility to tumor development. Clinical manifestations vary and include occult, verrucous, nodular, fibroblastic, mixed, and malignant (malevolent) types. The tumor is nonmetastasizing but can become very aggressive locally. Multiple tumors are common. All clinical types can be present in the same horse. No treatment protocol is universally effective. The tumor has a high risk of recurrence. Recurrent and large tumors are associated with poorer prognoses.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bovine papillomavirus type 1; Bovine papillomavirus type 2; Equine; Sarcoid; Skin tumor

Mesh:

Year:  2013        PMID: 24267682     DOI: 10.1016/j.cveq.2013.09.002

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN: 0749-0739            Impact factor:   1.792


  10 in total

1.  Periocular sarcoid with bone invasion in a Thoroughbred mare.

Authors:  Andres Giraldo; Chantale L Pinard; Brandon L Plattner; Marie-Soleil Dubois
Journal:  Can Vet J       Date:  2020-04       Impact factor: 1.008

2.  Autologous vaccination for the treatment of equine sarcoids: 18 cases (2009-2014).

Authors:  Caitlin C Rothacker; Ashley G Boyle; David G Levine
Journal:  Can Vet J       Date:  2015-07       Impact factor: 1.008

3.  Both tumour cells and infiltrating T-cells in equine sarcoids express FOXP3 associated with an immune-supressed cytokine microenvironment.

Authors:  A Douglas Wilson; Chelsea Hicks
Journal:  Vet Res       Date:  2016-05-09       Impact factor: 3.683

4.  Papillomaviruses: a systematic review.

Authors:  Rodrigo Pinheiro Araldi; Suely Muro Reis Assaf; Rodrigo Franco de Carvalho; Márcio Augusto Caldas Rocha de Carvalho; Jacqueline Mazzuchelli de Souza; Roberta Fiusa Magnelli; Diego Grando Módolo; Franco Peppino Roperto; Rita de Cassia Stocco; Willy Beçak
Journal:  Genet Mol Biol       Date:  2017-02-16       Impact factor: 1.771

5.  New approach for genomic characterisation of equine sarcoid-derived BPV-1/-2 using nanopore-based sequencing.

Authors:  Lien Gysens; Bert Vanmechelen; Maarten Haspeslagh; Ann Martens; Piet Maes
Journal:  Virol J       Date:  2022-01-06       Impact factor: 4.099

6.  ALVAC-fIL2, a feline interleukin-2 immunomodulator, as a treatment for sarcoids in horses: A pilot study.

Authors:  Corey Saba; Randall Eggleston; Andrew Parks; John Peroni; Eric Sjoberg; Shelbe Rice; Jesse Tyma; Jarred Williams; Deborah Grosenbaugh; A Timothy Leard
Journal:  J Vet Intern Med       Date:  2022-04-13       Impact factor: 3.175

7.  Expression of Cell-Cycle Regulatory Proteins pRb, Cyclin D1, and p53 Is Not Associated with Recurrence Rates of Equine Sarcoids.

Authors:  Giorgia Tura; Barbara Brunetti; Elena Brigandì; Riccardo Rinnovati; Giuseppe Sarli; Giancarlo Avallone; Luisa Vera Muscatello; Roberto Marcello La Ragione; Andy E Durham; Barbara Bacci
Journal:  Vet Sci       Date:  2022-09-01

8.  Extracellular matrix remodeling in equine sarcoid: an immunohistochemical and molecular study.

Authors:  Manuela Martano; Annunziata Corteggio; Brunella Restucci; Maria Ester De Biase; Giuseppe Borzacchiello; Paola Maiolino
Journal:  BMC Vet Res       Date:  2016-02-02       Impact factor: 2.741

9.  Evaluation of Hypoxia-Inducible Factor-1 Alpha (HIF-1α) in Equine Sarcoid: An Immunohistochemical and Biochemical Study.

Authors:  Manuela Martano; Gennaro Altamura; Karen Power; Brunella Restucci; Francesca Carella; Giuseppe Borzacchiello; Paola Maiolino
Journal:  Pathogens       Date:  2020-01-14

10.  Calcium Electroporation of Equine Sarcoids.

Authors:  Stine K Frandsen; Julie Gehl; Trine Tramm; Martin S Thoefner
Journal:  Animals (Basel)       Date:  2020-03-19       Impact factor: 2.752

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.